Xuan Zhao-Bo, Wang Ye-Ji, Xie Jun
Department of Neurosurgery, The First Hospital Affiliated to Jiamusi University, Jiamusi City, Heilongjiang Province 154002, People's Republic of China.
Department of Neurosurgery, Shanxian Haijiya Hospital, Heze City, Shandong Province 274300, People's Republic of China.
Onco Targets Ther. 2019 Aug 20;12:6721-6731. doi: 10.2147/OTT.S211725. eCollection 2019.
Anoctamin6 (ANO6) plays a crucial role in several cancers, whereas the specific role of ANO6 in glioblastoma is unclear.
Kaplan-Meier survival analysis was used to analysis the correlation between ANO6 and survival rate of patients with glioblastoma. Univariate Cox regression analysis was used to analysis the correlation among ANO6 expression level,and age, gender, WHO and overall survival rate. Immunohistocemical technique, RT-PCR and western blot were used to dected the ANO6 expression. CCK8, colony formation and transwell were used to detected cell viability, cell proliferation and cell invasion in glioblastoma cells transfected with sh-ANO6 and ANO6 overexpression. In addition, after SHG-44 cells trasfected with ANO6 overexpression were ERK inhibitor (PD98059), CCK8, colony formation and transwell were used to detected cell viability, cell proliferation and cell invasion. Western blot was used to detected ERK protein level and the phosphorylation level of ERK in T89G and U87MG cells tranfected wih sh-ANO6.
The results indicated that the ANO6 expression level was significantly associated with patients' age and tumor stage. Univariate Cox regression analysis showed that the ANO6 expression level, age, gender and tumor stage were not related to the overall survival rate. ANO6 inhibition significantly suppressed the viability, invasion and the ability of colony formation in glioma cells, while ANO6 overexpression led to the opposite results in SHG-44 cells. ANO6 knockdown strongly inhibits the phosphorylation level and nuclear translocation of extracellular signal-regulated kinase (ERK) protein to inhibit ERK signaling. ERK inhibitor significantly decreased the cell proliferation and invasion in SHG-44 cells transfected with sh-ANO6.
This study revealed that ANO6 activited ERK signaling pathway through promoting the nuclear translocation of ERK to increase the proliferation and invasion of glioblastoma cells.
anoctamin6(ANO6)在多种癌症中起关键作用,而ANO6在胶质母细胞瘤中的具体作用尚不清楚。
采用Kaplan-Meier生存分析来分析ANO6与胶质母细胞瘤患者生存率之间的相关性。单因素Cox回归分析用于分析ANO6表达水平与年龄、性别、世界卫生组织(WHO)分级及总生存率之间的相关性。采用免疫组织化学技术、逆转录-聚合酶链反应(RT-PCR)和蛋白质免疫印迹法检测ANO6表达。采用细胞计数试剂盒-8(CCK8)法、集落形成实验和Transwell实验检测转染小干扰RNA(sh-ANO6)和ANO6过表达的胶质母细胞瘤细胞的细胞活力、细胞增殖和细胞侵袭能力。此外,在ANO6过表达转染的SHG-44细胞中加入细胞外信号调节激酶(ERK)抑制剂(PD98059)后,采用CCK8法、集落形成实验和Transwell实验检测细胞活力、细胞增殖和细胞侵袭能力。采用蛋白质免疫印迹法检测转染sh-ANO6的T89G和U87MG细胞中ERK蛋白水平及ERK的磷酸化水平。
结果表明,ANO6表达水平与患者年龄和肿瘤分期显著相关。单因素Cox回归分析显示,ANO6表达水平、年龄、性别和肿瘤分期与总生存率无关。ANO6抑制显著抑制胶质瘤细胞的活力、侵袭和集落形成能力,而ANO6过表达在SHG-44细胞中导致相反的结果。ANO6敲低强烈抑制细胞外信号调节激酶(ERK)蛋白的磷酸化水平和核转位,从而抑制ERK信号通路。ERK抑制剂显著降低转染sh-ANO6的SHG-44细胞的细胞增殖和侵袭。
本研究表明,ANO6通过促进ERK核转位激活ERK信号通路,从而增加胶质母细胞瘤细胞的增殖和侵袭。